Jump to:
Paola Pagani is counsel in Ropes & Gray’s private equity transactions practice. She regularly represents private equity funds and corporate clients on a wide range of complex domestic and cross-border transactions, including mergers and acquisitions, leveraged buyouts, corporate reorganizations, divestitures, joint ventures and other investment transactions. She has advised on a number of notable deals in the Italian market across many industries, including pharmaceutical, technology, healthcare, food and industrials.
Experience
- Animalia, the leading Italian operator of veterinary clinics and a portfolio company of Charme Capital Partners, on multiple transactions, including:
- the sale of a majority stake of Animalia to Charme Capital Partners*
- a buy-and-build project through the acquisition of several (more than 50 to date and counting) veterinary clinics and the creation of a leading Italian network of veterinary clinics*
- Arca Space Capital, a private equity fund established through the partnership between Arca Fondi SGR and Space Capital Advisors, on the acquisition of Rogelfrut, an Italian leader in the production and distribution of fresh and frozen fruit-based ingredients
- Ardian, on multiple transactions, including:
- the acquisition of Irca, leading manufacturer of ingredients for the bakery and ice cream sectors*
- the acquisition of a majority stake in Dedalus Group, leading provider of IT solutions for the healthcare sector*
- the acquisition of a majority stake of Neopharmed Gentili, leading Italian pharmaceutical distributor*
- the sale of Italmatch Chemicals, a leading global specialty chemicals group, to Bain Capital*
- the sale of Irca, leading manufacturer of ingredients for the bakery and ice cream sectors, to The Carlyle Group*
- the acquisition of the entire share capital of Celli, leading provider of sustainable solutions for the beverage sector*
- the acquisition of a majority stake in Jakala, leading Italian martech group*
- the sale of Neopharmed Gentili, leading Italian pharmaceutical distributor, to a consortium composed by Ardian and NB Renaissance*
- the reorganization of the shareholdings of Dedalus Group, and the acquisition of a minority stake from the founder*
- Azelis, on multiple transactions, including:
- the acquisition of Came Chemical and Mineral Engineering*
- the acquisition of Deafarma*
- Dedalus Group (an Ardian portfolio company), on multiple add-on or disposal transactions, including:
- the acquisition of DXC Technology’s healthcare IT business*
- the acquisition of Agfa-Gevaert’s healthcare IT business*
- the acquisition of the entire share capital of Dobco Medical System*
- the acquisition of the entire share capital of Amphi Systems A/S*
- the sale of the entire corporate capital of Millennium*
- Iberis Capital on its investment in D-Orbit, in the context of a Euro 150 million Series C financing round*
- Italmatch Chemicals (an Ardian portfolio company), on multiple add-on transactions, including:
- the acquisition of the entire share capital of Water Science Technologies*
- the acquisition of the Afton Chemical’s metalworking fluid business*
- the acquisition of the entire share capital of Compass Chemical International from One Rock Capital Partners*
- the acquisition of Solvay’s phosphonates business and Ionquest 290 and Octyl Phosphonic Acid business*
- Jakala (an Ardian portfolio company), on the acquisition of the consultancy business unit operated by H-Farm*
- MooRER, a leading Italian luxury fashion brand, on the sale of a minority stake to Borletti Group*
- Neopharmed Gentili (an Ardian portfolio company), on multiple add-on transactions, including:
- the acquisition of entire share capital of Valeas*
- the acquisition of the lormetazepam product portfolio from Bayer*
- the acquisition of two sets of products from Sanofi*
* Experience prior to joining Ropes & Gray